Worries about new price controls on drugs have failed to wean investors away from pharma stocks in 2012. It was a hat trick for the BSE Healthcare Index which gained for the third consecutive...
While the BSE Healthcare index has gained 2.3 per cent since the beginning of November, Cipla has lost 2.2 per cent. The downslide came with growing concerns on growth opportunities and profitability.